Tredegar (NYSE:TG) Share Price Passes Above 200-Day Moving Average – Time to Sell?

Tredegar Corporation (NYSE:TG) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.84 and traded as high as $9.30. Tredegar shares last traded at $9.0850, with a volume of 215,479 shares.

Analysts Set New Price Targets

TG has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tredegar in a research report on Wednesday, January 21st. Wall Street Zen raised shares of Tredegar from a “hold” rating to a “strong-buy” rating in a research note on Saturday, November 15th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Tredegar presently has an average rating of “Sell”.

Tredegar Stock Performance

The firm’s 50-day moving average price is $7.98 and its two-hundred day moving average price is $7.84. The stock has a market cap of $317.16 million, a price-to-earnings ratio of -5.75 and a beta of 0.65.

Insider Activity

In other news, major shareholder John D. Gottwald sold 24,824 shares of Tredegar stock in a transaction that occurred on Friday, January 23rd. The shares were sold at an average price of $8.52, for a total transaction of $211,500.48. Following the sale, the insider owned 640,992 shares of the company’s stock, valued at approximately $5,461,251.84. The trade was a 3.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder James T. Gottwald sold 13,887 shares of the stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $8.57, for a total value of $119,011.59. Following the completion of the transaction, the insider owned 720,084 shares of the company’s stock, valued at $6,171,119.88. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 227,963 shares of company stock valued at $1,963,605. 5.80% of the stock is currently owned by company insiders.

Institutional Trading of Tredegar

Several institutional investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC lifted its stake in Tredegar by 31.4% during the first quarter. AQR Capital Management LLC now owns 17,158 shares of the basic materials company’s stock worth $132,000 after purchasing an additional 4,097 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Tredegar in the 1st quarter valued at $144,000. Janney Montgomery Scott LLC acquired a new position in Tredegar during the 2nd quarter worth about $413,000. Ritholtz Wealth Management boosted its holdings in Tredegar by 112.9% during the 2nd quarter. Ritholtz Wealth Management now owns 83,411 shares of the basic materials company’s stock valued at $734,000 after acquiring an additional 44,224 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Tredegar by 0.3% during the 2nd quarter. Geode Capital Management LLC now owns 589,275 shares of the basic materials company’s stock valued at $5,187,000 after acquiring an additional 1,506 shares during the period. Institutional investors and hedge funds own 79.24% of the company’s stock.

Tredegar Company Profile

Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar’s operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.

The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.